Literature DB >> 28474225

Trans-dissemination of exosomes from HIV-1-infected cells fosters both HIV-1 trans-infection in resting CD4+ T lymphocytes and reactivation of the HIV-1 reservoir.

Chiara Chiozzini1, Claudia Arenaccio1, Eleonora Olivetta1, Simona Anticoli1, Francesco Manfredi1, Flavia Ferrantelli1, Gabriella d'Ettorre2, Ivan Schietroma2, Mauro Andreotti1, Maurizio Federico3.   

Abstract

Intact HIV-1 and exosomes can be internalized by dendritic cells (DCs) through a common pathway leading to their transmission to CD4+ T lymphocytes by means of mechanisms defined as trans-infection and trans-dissemination, respectively. We previously reported that exosomes from HIV-1-infected cells activate both uninfected quiescent CD4+ T lymphocytes, which become permissive to HIV-1, and latently infected cells, with release of HIV-1 particles. However, nothing is known about the effects of trans-dissemination of exosomes produced by HIV-1-infected cells on uninfected or latently HIV-1-infected CD4+ T lymphocytes. Here, we report that trans-dissemination of exosomes from HIV-1-infected cells induces cell activation in resting CD4+ T lymphocytes, which appears stronger with mature than immature DCs. Using purified preparations of both HIV-1 and exosomes, we observed that mDC-mediated trans-dissemination of exosomes from HIV-1-infected cells to resting CD4+ T lymphocytes induces efficient trans-infection and HIV-1 expression in target cells. Most relevant, when both mDCs and CD4+ T lymphocytes were isolated from combination anti-retroviral therapy (ART)-treated HIV-1-infected patients, trans-dissemination of exosomes from HIV-1-infected cells led to HIV-1 reactivation from the viral reservoir. In sum, our data suggest a role of exosome trans-dissemination in both HIV-1 spread in the infected host and reactivation of the HIV-1 reservoir.

Entities:  

Keywords:  GPR37 Cell; GW4869; Iodixanol; Virological Synapse; cART Patient

Mesh:

Substances:

Year:  2017        PMID: 28474225     DOI: 10.1007/s00705-017-3391-4

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  8 in total

1.  Effects of exosome on the activation of CD4+ T cells in rhesus macaques: a potential application for HIV latency reactivation.

Authors:  Xiaowu Hong; Blake Schouest; Huanbin Xu
Journal:  Sci Rep       Date:  2017-11-15       Impact factor: 4.379

Review 2.  Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved?

Authors:  Laís Teodoro da Silva; Bruna Tereso Santillo; Alexandre de Almeida; Alberto Jose da Silva Duarte; Telma Miyuki Oshiro
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

Review 3.  Dendritic Cells, the Double Agent in the War Against HIV-1.

Authors:  Alba Martín-Moreno; Mª Angeles Muñoz-Fernández
Journal:  Front Immunol       Date:  2019-10-23       Impact factor: 7.561

Review 4.  Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseases.

Authors:  Carolyn Tallon; Kristen R Hollinger; Arindom Pal; Benjamin J Bell; Rana Rais; Takashi Tsukamoto; Kenneth W Witwer; Norman J Haughey; Barbara S Slusher
Journal:  Drug Discov Today       Date:  2021-03-31       Impact factor: 8.369

5.  Inefficient HIV-1 trans Infection of CD4+ T Cells by Macrophages from HIV-1 Nonprogressors Is Associated with Altered Membrane Cholesterol and DC-SIGN.

Authors:  Diana C DeLucia; Charles R Rinaldo; Giovanna Rappocciolo
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

Review 6.  Exosomes as Mediators of Cell-to-Cell Communication in Thyroid Disease.

Authors:  Yi Wang; Feng Xu; Jia-Yu Zhong; Xiao Lin; Su-Kang Shan; Bei Guo; Ming-Hui Zheng; Ling-Qing Yuan
Journal:  Int J Endocrinol       Date:  2020-04-28       Impact factor: 3.257

Review 7.  Extracellular Vesicles as a New Promising Therapy in HIV Infection.

Authors:  Maria A Navarrete-Muñoz; Carlos Llorens; José M Benito; Norma Rallón
Journal:  Front Immunol       Date:  2022-01-04       Impact factor: 7.561

8.  Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control.

Authors:  Eva Poveda; Andrés Tabernilla; Wendy Fitzgerald; Ángel Salgado-Barreira; Marta Grandal; Alexandre Pérez; Ana Mariño; Hortensia Álvarez; Nieves Valcarce; Juan González-García; José Ignacio Bernardino; Félix Gutierrez; Hisashi Fujioka; Manuel Crespo; Ezequiel Ruiz-Mateos; Leonid Margolis; Michael M Lederman; Michael L Freeman
Journal:  J Infect Dis       Date:  2022-03-15       Impact factor: 7.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.